Chester County News and Community Website
PHILADELPHIA, PA — FORE Biotherapeutics announced that its investigational therapy plixorafenib has cleared an interim efficacy analysis in the Phase 2 FORTE basket study for patients with recurrent or progressive …
Fore Bio’s Plixorafenib Clears Interim Review in Brain Tumor Trial Read More
PHILADELPHIA, PA — A groundbreaking discovery from Dr. Filippo Veglia’s lab at The Wistar Institute has revealed how aggressive brain tumors reprogram immune cells, turning them from cancer-fighters into enablers …
Wistar Researchers Uncover Key Mechanism Behind Brain Tumor Immune Suppression Read More PHILADELPHIA, PA — The Wistar Institute, led by Dr. David B. Weiner, has announced successful preclinical tests of a groundbreaking immune therapy for glioblastoma, a highly aggressive brain cancer with …
Wistar Institute Develops Promising Immune Therapy for Glioblastoma Read More
PLYMOUTH MEETING, PA — In what is hailed as a milestone in pediatric oncology, the National Comprehensive Cancer Network® (NCCN®) has released the first-ever treatment recommendations for neuroblastoma. This rare …
Game-Changing Guidelines for Neuroblastoma Treatment Published by NCCN Read More